These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34465322)

  • 1. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a.
    Li F; Wang D; Wang H; Chen L; Sun X; Wan Y
    Respir Res; 2021 Aug; 22(1):239. PubMed ID: 34465322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Siah2 ubiquitin ligase ameliorates monocrotaline-induced pulmonary arterial remodeling through inactivation of YAP.
    Wang Q; Shi W; Zhang Q; Feng W; Wang J; Zhai C; Yan X; Li M
    Life Sci; 2020 Feb; 242():117159. PubMed ID: 31837334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
    Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
    [No Abstract]   [Full Text] [Related]  

  • 5. MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-β1/smad2/3 signaling.
    Li P; Song J; Du H; Lu Y; Dong S; Zhou S; Guo Z; Wu H; Zhao X; Qin Y; Zhu N
    J Mol Cell Cardiol; 2021 Dec; 161():9-22. PubMed ID: 34339758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ubiquitin proteasome function prevents monocrotaline-induced pulmonary arterial remodeling.
    Zhu Y; Wu Y; Shi W; Wang J; Yan X; Wang Q; Liu Y; Yang L; Gao L; Li M
    Life Sci; 2017 Mar; 173():36-42. PubMed ID: 28212825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel alleviates monocrotaline-induced pulmonary arterial hypertension via inhibition of FoxO1-mediated autophagy.
    Feng W; Wang J; Yan X; Zhai C; Shi W; Wang Q; Zhang Q; Li M
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):605-613. PubMed ID: 30683943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Huang W; Zhou H; He Y; Wang A; Wang B; Chen Y; Liu C; Wang H; Xie W; Kong H
    Exp Cell Res; 2024 Aug; 441(1):114154. PubMed ID: 38996959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of AMPK Prevents Monocrotaline-Induced Extracellular Matrix Remodeling of Pulmonary Artery.
    Li S; Han D; Zhang Y; Xie X; Ke R; Zhu Y; Liu L; Song Y; Yang L; Li M
    Med Sci Monit Basic Res; 2016 Mar; 22():27-33. PubMed ID: 26978596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
    Zhai C; Zhang N; Wang J; Cao M; Luan J; Liu H; Zhang Q; Zhu Y; Xue Y; Li S
    Lung; 2022 Oct; 200(5):619-631. PubMed ID: 36107242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grape seed proanthocyanidin reverses pulmonary vascular remodeling in monocrotaline-induced pulmonary arterial hypertension by down-regulating HSP70.
    Chen F; Wang H; Yan J; Lai J; Cai S; Yuan L; Zheng S
    Biomed Pharmacother; 2018 May; 101():123-128. PubMed ID: 29482057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
    Yang HT; Wang G; Zhu PC; Xiao ZY
    Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W; Zhai C; Feng W; Wang J; Zhu Y; Li S; Wang Q; Zhang Q; Yan X; Chai L; Liu P; Chen Y; Li M
    Life Sci; 2018 Oct; 210():140-149. PubMed ID: 30179628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Tang C; Luo Y; Li S; Huang B; Xu S; Li L
    Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.
    Liu J; Wang W; Wang L; Qi XM; Sha YH; Yang T
    Chin Med J (Engl); 2020 Jan; 133(1):49-60. PubMed ID: 31923104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-181b-5p inhibits endothelial-mesenchymal transition in monocrotaline-induced pulmonary arterial hypertension by targeting endocan and TGFBR1.
    Zhao H; Wang Y; Zhang X; Guo Y; Wang X
    Toxicol Appl Pharmacol; 2020 Jan; 386():114827. PubMed ID: 31734320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
    Le Ribeuz H; Courboulin A; Ghigna MR; Lambert M; Hautefort A; Humbert M; Montani D; Cohen-Kaminsky S; Perros F; Antigny F
    Respir Res; 2020 Jul; 21(1):186. PubMed ID: 32678044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of cordycepin in the treatment of pulmonary arterial hypertension in rats based on metabonomics and transcriptomics.
    Lin J; Chen R; Liao H; Zhang Y; Zheng Z; Hong C
    Sci Rep; 2024 May; 14(1):12431. PubMed ID: 38816406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Chloro-DL-phenylalanine protects against monocrotaline‑induced pulmonary vascular remodeling and lung inflammation.
    Bai Y; Wang HM; Liu M; Wang Y; Lian GC; Zhang XH; Kang J; Wang HL
    Int J Mol Med; 2014 Feb; 33(2):373-82. PubMed ID: 24337018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.